sameAs
P1346
Brain changes in diabetes mellitus patients with gastrointestinal symptomsEvolving paradigms in the treatment of opioid-induced bowel dysfunctionNutrition in chronic pancreatitisClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionHuman experimental pain models for assessing the therapeutic efficacy of analgesic drugsAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetesA Randomized Controlled Trial on the Effect of Tapentadol and Morphine on Conditioned Pain Modulation in Healthy VolunteersGastrointestinal symptoms in type-1 diabetes: is it all about brain plasticity?Evaluation of the biliary tract in patients with functional biliary symptoms.Altered brain microstructure assessed by diffusion tensor imaging in patients with diabetes and gastrointestinal symptoms.Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin.Electrophysiology as a tool to unravel the origin of pancreatic pain.A cortical source localization analysis of resting EEG data after remifentanil infusion.Understanding the sensory irregularities of esophageal disease.Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial.A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans.Geometric and mechanosensory properties of the sigmoid colon evaluated with magnetic resonance imaging.Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut.Unexplained chest/epigastric pain in patients with normal endoscopy as a predictor for ischemic heart disease and mortality: a Danish 10-year cohort study.Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.Applying concepts of generalizability theory on data from experimental pain studies to investigate reliability.Cardiac vagal tone, a non-invasive measure of parasympathetic tone, is a clinically relevant tool in Type 1 diabetes mellitus.Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance.Inverse modeling on decomposed electroencephalographic data: a way forward?Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy.Characterization of cortical source generators based on electroencephalography during tonic pain.Functional oesophago-gastric junction imaging.Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.Three-dimensional surface model analysis in the gastrointestinal tract.Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis.Brain activity in rectosigmoid pain: unravelling conditioning pain modulatory pathways.Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.Rectal sensitivity in diabetes patients with symptoms of gastroparesis.The role of pain catastrophizing in experimental pain perception.Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome.Referred pain as an indicator for neural plasticity.Differences in perception and brain activation following stimulation by large versus small area cutaneous surface electrodes.Incidence of adenocarcinoma among patients with Barrett's esophagus.Differences between opioids: pharmacological, experimental, clinical and economical perspectives
P50
Q26769999-DD616F5C-E31B-4341-B316-0B9657260E84Q26777692-85F6D8B1-8EA2-4D88-98F3-D0EC85377FA7Q26861371-4DA0DD89-7E5C-49AA-AB60-0431D3A7EBE1Q26995944-CB444711-BFAA-4E9E-AAAC-6383721C9EFEQ26999242-44072D2C-105C-4D49-941B-28E70FDA001AQ28077101-B7C440E7-0F1A-45C8-921B-A60DA3E00CB0Q28548331-2947FDD8-A91B-436D-BD32-6B939BE1F04FQ30393267-2BA2DABE-C171-4641-AD83-C008667C5D7DQ30433393-812909C6-AA4D-4F8F-8D40-61FF5E87CAFCQ30576972-03181D5D-B483-4864-8C79-477E4ABF20E3Q30743686-D22C73ED-17ED-4128-B84F-7A97488A208FQ30828581-01DF6031-54E0-466B-A985-9B8F551FFEF3Q30852102-30440547-54A1-43A3-ADC3-954E21BA19ECQ31047626-700200F9-40EB-4504-9313-F159AC231A14Q31081451-D03921ED-2AFA-4DF3-9596-D1BACC4274D0Q31126392-0733EA17-02F1-4EE7-AEF6-93CE3C06E69CQ33280279-0865E6D9-4F3E-476F-98F3-7374E640C813Q33304745-CFEEBA55-1ECE-47FB-82DD-9134AB20AFE9Q33351803-8ACF7E36-C8B3-4F26-AE5F-5EE2E7674F2CQ33384053-79D4F7BC-A7D7-4229-8F23-60D9C36ACE8BQ33434104-0B79ADA9-435C-4D2F-823B-9240F542C883Q33455574-0BF8FCA5-8085-48F7-BCCD-93B24E240760Q33469889-683F7681-1B4E-46BF-A487-CA68783F3A5DQ33479505-BC0874C7-AB4D-488D-BD19-01030444B283Q33485491-8B0B4658-E00F-4FEC-83B5-653810E634E4Q33685438-E9B2F567-24DD-4F2A-96D2-A2FB2690752EQ33812755-8ACCE40E-0F8C-4EB2-89E0-CA73FF507C64Q33867679-F8C4C4C2-FD9D-4E0B-A714-B53A133B3320Q33867705-2DF14DE7-249A-4DDB-B724-134C751A3AAEQ33867716-ED86C6EF-0817-4DF6-A1BA-BA3E6DB250ECQ33910832-FD23F9DF-644A-4A35-86BE-12FC62900968Q34021504-A3AEAF7D-065D-4334-A5E8-E162CD8436D8Q34026235-8D987ADE-73E1-4F42-9D76-826BC52C8CEFQ34033661-C7F3207F-E184-4C09-8FE9-F6CDB0171F2BQ34038868-32E6CB8A-693C-4A2D-A399-B70B508CB0D5Q34062433-1217216C-BE14-4BC7-98DA-D2201FEB1FD2Q34094093-395022C3-4FCD-4CD6-B0D3-7F2458FC22F4Q34159976-F0746619-89B0-4952-AD15-16818D06054FQ34223900-49EDE279-7B35-4262-92EC-93984C78FF2DQ34272502-8FBCC833-C112-443C-9C31-4088DEF0ED90
P50
description
Deens onderzoeker
@nl
hulumtues
@sq
investigador danés
@ast
investigador danés
@es
læge og forsker fra Aalborg
@da
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Asbjørn Mohr Drewes
@ast
Asbjørn Mohr Drewes
@ca
Asbjørn Mohr Drewes
@da
Asbjørn Mohr Drewes
@de
Asbjørn Mohr Drewes
@en
Asbjørn Mohr Drewes
@es
Asbjørn Mohr Drewes
@fo
Asbjørn Mohr Drewes
@fr
Asbjørn Mohr Drewes
@ga
Asbjørn Mohr Drewes
@is
type
label
Asbjørn Mohr Drewes
@ast
Asbjørn Mohr Drewes
@ca
Asbjørn Mohr Drewes
@da
Asbjørn Mohr Drewes
@de
Asbjørn Mohr Drewes
@en
Asbjørn Mohr Drewes
@es
Asbjørn Mohr Drewes
@fo
Asbjørn Mohr Drewes
@fr
Asbjørn Mohr Drewes
@ga
Asbjørn Mohr Drewes
@is
prefLabel
Asbjørn Mohr Drewes
@ast
Asbjørn Mohr Drewes
@ca
Asbjørn Mohr Drewes
@da
Asbjørn Mohr Drewes
@de
Asbjørn Mohr Drewes
@en
Asbjørn Mohr Drewes
@es
Asbjørn Mohr Drewes
@fo
Asbjørn Mohr Drewes
@fr
Asbjørn Mohr Drewes
@ga
Asbjørn Mohr Drewes
@is
P106
P1153
35477645700
56427702200
P166
P21
P27
P31
P496
0000-0001-7465-964X
P569
1956-01-01T00:00:00Z